LS Investment Advisors LLC trimmed its holdings in Waters Co. (NYSE:WAT) by 14.1% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,017 shares of the medical instruments supplier’s stock after selling 495 shares during the quarter. LS Investment Advisors LLC’s holdings in Waters were worth $569,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of the business. Bank of New York Mellon Corp boosted its position in shares of Waters by 156.1% during the 2nd quarter. Bank of New York Mellon Corp now owns 4,358,976 shares of the medical instruments supplier’s stock valued at $843,852,000 after acquiring an additional 2,657,055 shares during the last quarter. Morgan Stanley boosted its position in shares of Waters by 188.1% during the 3rd quarter. Morgan Stanley now owns 527,562 shares of the medical instruments supplier’s stock valued at $102,707,000 after acquiring an additional 344,432 shares during the last quarter. Select Equity Group L.P. boosted its position in shares of Waters by 81.8% during the 3rd quarter. Select Equity Group L.P. now owns 406,245 shares of the medical instruments supplier’s stock valued at $79,088,000 after acquiring an additional 182,841 shares during the last quarter. Nordea Investment Management AB boosted its position in shares of Waters by 3,557.4% during the 3rd quarter. Nordea Investment Management AB now owns 154,597 shares of the medical instruments supplier’s stock valued at $30,098,000 after acquiring an additional 150,370 shares during the last quarter. Finally, Man Group plc boosted its position in shares of Waters by 61.4% during the 3rd quarter. Man Group plc now owns 313,891 shares of the medical instruments supplier’s stock valued at $61,109,000 after acquiring an additional 119,451 shares during the last quarter. Institutional investors and hedge funds own 96.14% of the company’s stock.

NYSE:WAT opened at $231.00 on Monday. Waters Co. has a fifty-two week low of $167.93 and a fifty-two week high of $233.48. The firm has a market cap of $17.50 billion, a P/E ratio of 27.86, a P/E/G ratio of 2.28 and a beta of 1.17. The company has a debt-to-equity ratio of 0.61, a quick ratio of 2.01 and a current ratio of 2.26.

Waters (NYSE:WAT) last released its quarterly earnings results on Wednesday, January 23rd. The medical instruments supplier reported $2.87 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.64 by $0.23. Waters had a return on equity of 34.18% and a net margin of 24.54%. The company had revenue of $715.00 million for the quarter, compared to analyst estimates of $702.74 million. During the same quarter in the prior year, the firm posted $2.51 EPS. Waters’s quarterly revenue was up 4.0% compared to the same quarter last year. Sell-side analysts forecast that Waters Co. will post 9.35 EPS for the current year.

In related news, Director Christopher A. Kuebler sold 8,000 shares of the stock in a transaction on Friday, November 16th. The stock was sold at an average price of $199.67, for a total transaction of $1,597,360.00. Following the sale, the director now owns 18,911 shares in the company, valued at approximately $3,775,959.37. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Thomas P. Salice sold 2,000 shares of the stock in a transaction on Wednesday, January 30th. The shares were sold at an average price of $231.59, for a total value of $463,180.00. Following the sale, the director now owns 20,010 shares in the company, valued at approximately $4,634,115.90. The disclosure for this sale can be found here. Insiders have sold a total of 97,249 shares of company stock worth $20,981,857 in the last 90 days. 0.98% of the stock is currently owned by insiders.

A number of research firms have recently commented on WAT. Zacks Investment Research upgraded Waters from a “hold” rating to a “buy” rating and set a $203.00 target price for the company in a research report on Monday, December 31st. BTIG Research increased their target price on Waters to $260.00 and gave the company a “buy” rating in a research report on Thursday, January 24th. TheStreet upgraded Waters from a “c+” rating to a “b” rating in a research report on Thursday, January 17th. Barclays reiterated a “hold” rating and set a $200.00 target price on shares of Waters in a research report on Friday, January 25th. Finally, JPMorgan Chase & Co. downgraded Waters from a “neutral” rating to an “underweight” rating and lowered their target price for the company from $185.00 to $180.00 in a research report on Wednesday, December 12th. Two equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and three have assigned a buy rating to the company. Waters has an average rating of “Hold” and an average target price of $208.99.

ILLEGAL ACTIVITY WARNING: This piece was reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this piece on another website, it was illegally stolen and republished in violation of United States and international trademark & copyright laws. The legal version of this piece can be viewed at https://www.thecerbatgem.com/2019/02/11/waters-co-wat-holdings-trimmed-by-ls-investment-advisors-llc.html.

Waters Profile

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in the United States, Europe, Asia, and internationally. It designs, manufactures, sells, and services high and ultra performance liquid chromatography technology, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Recommended Story: What are trading strategies for the 52-week high/low?

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.